000661 长春高新
交易中 12-23 13:05:03
资讯
新帖
简况
长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准
智通财经 · 12-20 22:39
长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准
长春高新(000661.SZ)下属公司获得一项医疗器械注册证
智通财经 · 12-18
长春高新(000661.SZ)下属公司获得一项医疗器械注册证
长春高新最新公告：下属公司上海赛增医疗科技有限公司获得医疗器械注册证
证券之星 · 12-18
长春高新最新公告：下属公司上海赛增医疗科技有限公司获得医疗器械注册证
长春高新(000661.SZ)：GenSci122片临床试验申请获批准
智通财经 · 12-17
长春高新(000661.SZ)：GenSci122片临床试验申请获批准
长春高新最新公告：子公司GenSci122片临床试验申请获得批准
证券之星 · 12-17
长春高新最新公告：子公司GenSci122片临床试验申请获得批准
12月17日长春高新现285.48万元大宗交易
证券之星 · 12-17
12月17日长春高新现285.48万元大宗交易
长春高新12月17日现1笔大宗交易 成交金额285.48万元
新浪证券-红岸工作室 · 12-17
长春高新12月17日现1笔大宗交易 成交金额285.48万元
抓住低吸机会！继长春高新后，真正有核心竞争力的A股医药龙头值得关注（名单），谁将涨成下一“千倍股”？
市场资讯 · 12-04
抓住低吸机会！继长春高新后，真正有核心竞争力的A股医药龙头值得关注（名单），谁将涨成下一“千倍股”？
长春高新(000661.SZ)已累计回购0.34%股份 耗资约1.5亿元
智通财经 · 12-02
长春高新(000661.SZ)已累计回购0.34%股份 耗资约1.5亿元
长春高新(000661.SZ)：黄体酮注射液(Ⅱ)纳入国家医保目录
智通财经 · 11-28
长春高新(000661.SZ)：黄体酮注射液(Ⅱ)纳入国家医保目录
长春高新最新公告：黄体酮注射液纳入国家医保目录
证券之星 · 11-28
长春高新最新公告：黄体酮注射液纳入国家医保目录
长春高新：黄体酮注射液纳入国家医保目录
美港电讯 · 11-28
长春高新：黄体酮注射液纳入国家医保目录
长春高新11月28日现1笔大宗交易 成交金额200.62万元
新浪证券-红岸工作室 · 11-28
长春高新11月28日现1笔大宗交易 成交金额200.62万元
11月28日长春高新现1笔大宗交易 机构净买入200.62万元
证券之星 · 11-28
11月28日长春高新现1笔大宗交易 机构净买入200.62万元
长春高新(SZ000661):公司将合理安排经营发展路径，遵守法律法规要求，审慎进行资本运作
问董秘 · 11-27
长春高新(SZ000661):公司将合理安排经营发展路径，遵守法律法规要求，审慎进行资本运作
一位投资长春高新的老股民坦言：5年前5178点买入5万长春高新，无视涨跌到现在什么光景？真正的钱生钱
市场资讯 · 11-26
一位投资长春高新的老股民坦言：5年前5178点买入5万长春高新，无视涨跌到现在什么光景？真正的钱生钱
国金证券：给予长春高新买入评级
证券之星 · 11-21
国金证券：给予长春高新买入评级
《股市简讯》中国长春高新一度劲扬5.6%，拟以3-5亿元回购公司股份
路透中文 · 11-18
《股市简讯》中国长春高新一度劲扬5.6%，拟以3-5亿元回购公司股份
长春高新最新公告：拟3亿元-5亿元回购股份
证券之星 · 11-15
长春高新最新公告：拟3亿元-5亿元回购股份
长春高新(000661.SZ)拟回购3亿元至5亿元公司股份 已获3.5亿元回购贷款承诺
智通财经 · 11-15
长春高新(000661.SZ)拟回购3亿元至5亿元公司股份 已获3.5亿元回购贷款承诺
暂无数据
公司概况
公司名称：
长春高新技术产业(集团)股份有限公司
所属行业：
医药制造业
上市日期：
1996-12-18
主营业务：
长春高新技术产业(集团)股份有限公司的主营业务为生物制药及中成药的研发、生产和销售，辅以房地产开发等业务。公司的主要产品为聚乙二醇重组人生长激素注射液、重组人生长激素、注射用重组人促卵泡激素、冻干水痘减毒活疫苗、人用狂犬病疫苗、血栓心脉宁片、银花泌炎灵片等。
发行价格：
8.80
{"stockData":{"symbol":"000661","market":"SZ","secType":"STK","nameCN":"长春高新","latestPrice":100.83,"timestamp":1734930303000,"preClose":101,"halted":0,"volume":2107705,"delay":0,"floatShares":400000000,"shares":408000000,"eps":9.091,"marketStatus":"交易中","marketStatusCode":2,"change":-0.17,"latestTime":"12-23 13:05:03","open":101,"high":101.43,"low":100.48,"amount":213000000,"amplitude":0.0094,"askPrice":100.83,"askSize":4,"bidPrice":100.81,"bidSize":14,"shortable":0,"etf":0,"ttmEps":9.091,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1734937200000},"adr":0,"adjPreClose":101,"symbolType":"stock","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":111.1,"lowLimit":90.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":407981429,"pbRate":1.79,"roa":"--","roe":"12.43%","epsLYR":11.21,"committee":0.5,"marketValue":41137000000,"floatMarketCap":40284000000,"peRate":11.09119,"changeRate":-0.0017,"turnoverRate":0.0053,"status":1},"requestUrl":"/m/hq/s/000661/tweets","defaultTab":"tweets","newsList":[{"id":"2492444532","title":"长春高新(000661.SZ)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444532","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444532?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:39","pubTimestamp":1734705546,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)公告，公司控股子公司——长春百克生物科技股份公司(简称“百克生物”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，Ⅱ型单纯疱疹病毒mRNA疫苗的临床试验申请(预防由Ⅱ型单纯疱疹病毒感染导致的生殖器疱疹)获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0188","BK1583","BK0075","BK0057","BK1141","03347","BK1576","BK0028","000661","159646","BK0046"],"gpt_icon":0},{"id":"2492909411","title":"长春高新(000661.SZ)下属公司获得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492909411","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492909411?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:01","pubTimestamp":1734519695,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)发布公告，近日，公司下属公司上海赛增医疗科技有限公司收到上海市药品监督管理局颁发的《医疗器械注册证》(体外诊断试剂)。产品名称：促黄体生成素检测试剂盒(荧光免疫层析法)，该产品用于体外定量检测人体尿液样本中促黄体生成。该产品医疗器械注册证的取得，进一步丰富了公司产品线，将对公司业务发展具有正面影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1222","BK0057","000661","09997","BK1100","BK0028","159883","BK0188","09996","BK0075","BK1574","BK1583","BK0046"],"gpt_icon":0},{"id":"2492590632","title":"长春高新最新公告：下属公司上海赛增医疗科技有限公司获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2492590632","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492590632?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:29","pubTimestamp":1734517777,"startTime":"0","endTime":"0","summary":"长春高新公告，公司下属公司上海赛增医疗科技有限公司收到上海市药品监督管理局颁发的《医疗器械注册证》（体外诊断试剂）。产品名称为促黄体生成素检测试剂盒(荧光免疫层析法)，注册证号为沪械注准20242400432，有效期为2024年12月13日至2029年12月12日。该产品用于体外定量检测人体尿液样本中促黄体生成素(LH)的含量，主要用于评价垂体内分泌功能。该产品医疗器械注册证的取得将对公司业务发展具有正面影响，但公司目前无法预测其对未来营业收入的影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800032685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","159883","BK1574","BK0028","BK0075","159891","BK0239","BK0188","BK1100","BK0046","BK0057","BK1222","09996","000661","09997"],"gpt_icon":0},{"id":"2492932937","title":"长春高新(000661.SZ)：GenSci122片临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492932937","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492932937?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:58","pubTimestamp":1734433117,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)公告，公司子公司——长春金赛药业有限责任公司(简称“金赛药业”)收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，金赛药业GenSci122片的临床试验申请(用于晚期实体瘤)获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","BK0188","BK0239","BK0028","000661","BK1141","BK0057","BK1583","BK0046","BK0075","BK1576"],"gpt_icon":0},{"id":"2492893472","title":"长春高新最新公告：子公司GenSci122片临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492893472","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492893472?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:30","pubTimestamp":1734431442,"startTime":"0","endTime":"0","summary":"长春高新公告称，其子公司金赛药业收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，GenSci122片的临床试验申请获得批准。GenSci122片为化学药品1类新药，是金赛药业自主研发的一款具有新型结构的选择性小分子KIF18A抑制剂，用于治疗晚期实体瘤。如临床试验进展顺利，将有利于公司拓宽业务结构、优化产品结构，并丰富完善战略领域产品线布局、提升公司核心竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700032323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0057","BK1583","BK0188","BK0046","000661","BK0075","BK1141","BK0239","BK0028","03347"],"gpt_icon":0},{"id":"2492093376","title":"12月17日长春高新现285.48万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2492093376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492093376?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:07","pubTimestamp":1734426467,"startTime":"0","endTime":"0","summary":"证券之星消息，12月17日长春高新发生大宗交易，交易数据如下：大宗交易成交价格102.69元，成交2.78万股，成交金额285.48万元，买方营业部为机构专用，卖方营业部为机构专用。近三个月该股共发生2笔大宗交易，合计成交468.0手。该股近期无解禁股上市。截至2024年12月17日收盘，长春高新(000661)报收于102.69元，下跌0.95%，换手率0.72%，成交量2.86万手，成交额2.95亿元。该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为137.9。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700028485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0028","BK0075","BK0188","BK0057","000661"],"gpt_icon":0},{"id":"2492935517","title":"长春高新12月17日现1笔大宗交易 成交金额285.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492935517","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492935517?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:00","pubTimestamp":1734426000,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月17日，长春高新收跌0.95%，收盘价为102.69元，发生1笔大宗交易，合计成交量2.78万股，成交金额285.48万元。 第1笔成交价格为102.69元，成交2.78万股，成交金额285.48万元，溢价率为0.00%，买方营业部为机构专用，卖方营业部为机构专用。 进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为486.1万元。该股近5个交易日累计下跌5.18%，主力资金合计净流出1.44亿元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-12-17/doc-inczuerr1654968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0057","BK0075","BK0188","BK0239","BK0028","000661"],"gpt_icon":0},{"id":"2488152343","title":"抓住低吸机会！继长春高新后，真正有核心竞争力的A股医药龙头值得关注（名单），谁将涨成下一“千倍股”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2488152343","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488152343?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:41","pubTimestamp":1733301660,"startTime":"0","endTime":"0","summary":"话不多说，直接上具有核心竞争力的原料药个股：天宇股份：新产能逐步释放，带动公司快速成长公司主要业务：心脑血管类药物、降血糖药物、降血脂类药物、抗凝血类药物和抗哮喘类药物等医药中间体和原料药，其中缬沙坦是全球最大的供应商之一。近几年随着沙坦类产品竞争格局变化，带动公司近几年业绩快速增长，2019年公司营业收入达到21.2亿元，同比增长43.9%，实现归母净利润5.8亿元，同比增长256%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-04/doc-incyhuer3919694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0075","BK1161","BK0057","BK1574","BK1515","BK0188","09939","BK0046","159938","000661","399300","BK0028","159982","BK0239"],"gpt_icon":0},{"id":"2488622671","title":"长春高新(000661.SZ)已累计回购0.34%股份 耗资约1.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488622671","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488622671?lang=zh_cn&edition=full","pubTime":"2024-12-02 18:44","pubTimestamp":1733136247,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)发布公告，截至2024年11月30日，公司累计通过回购专用证券账户，以集中竞价交易方式回购公司股份135.91万股，占公司总股本的0.34%，其中最高成交价为112.25元/股，最低成交价为106.62元/股，合计成交金额为人民币1.5亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1219138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0057","BK0188","BK0239","000661","BK0075","BK0046"],"gpt_icon":0},{"id":"2486607398","title":"长春高新(000661.SZ)：黄体酮注射液(Ⅱ)纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2486607398","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486607398?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:23","pubTimestamp":1732785813,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)发布公告，根据国家医保局、人力资源社会保障部关于印发《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》的通知(医保发〔2024〕33号)，公司控股子公司长春金赛药业有限责任公司的金赛欣®黄体酮注射液(Ⅱ)(1.112ml:25mg)纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》。此次金赛欣®黄体酮注射液(Ⅱ)纳入《2024年国家医保目录》，标志着金赛欣®黄体酮注射液(Ⅱ)成为辅助生殖领域第一个国谈药品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","000661","BK0028","BK0057","BK0239","BK0075","BK0188"],"gpt_icon":0},{"id":"2486984843","title":"长春高新最新公告：黄体酮注射液纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2486984843","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486984843?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:20","pubTimestamp":1732785637,"startTime":"0","endTime":"0","summary":"长春高新公告，控股子公司长春金赛药业有限责任公司的金赛欣®黄体酮注射液纳入《国家基本医疗保险、工伤保险和生育保险药品目录》。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800029027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0075","BK0057","000661","BK0188","BK0046"],"gpt_icon":0},{"id":"2486035360","title":"长春高新：黄体酮注射液纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2486035360","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486035360?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:17","pubTimestamp":1732785456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0046","BK0028","000661","BK0057","BK0239","BK0188","BK0075"],"gpt_icon":0},{"id":"2486360735","title":"长春高新11月28日现1笔大宗交易 成交金额200.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486360735","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486360735?lang=zh_cn&edition=full","pubTime":"2024-11-28 17:00","pubTimestamp":1732784400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 11月28日，长春高新收跌2.17%，收盘价为105.59元，发生1笔大宗交易，合计成交量1.9万股，成交金额200.62万元。 第1笔成交价格为105.59元，成交1.90万股，成交金额200.62万元，溢价率为0.00%，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为200.62万元。该股近5个交易日累计下跌6.57%，主力资金合计净流出1.82亿元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-28/doc-incxrfqm6053103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0057","BK0046","000661","BK0028","BK0188","BK0239","BK0075"],"gpt_icon":0},{"id":"2486362701","title":"11月28日长春高新现1笔大宗交易 机构净买入200.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486362701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486362701?lang=zh_cn&edition=full","pubTime":"2024-11-28 16:44","pubTimestamp":1732783455,"startTime":"0","endTime":"0","summary":"证券之星消息，11月28日长春高新发生大宗交易，交易数据如下：大宗交易成交价格105.59元，成交1.9万股，成交金额200.62万元，买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。近三个月该股共发生1笔大宗交易，合计成交190.0手。该股近期无解禁股上市。截至2024年11月28日收盘，长春高新(000661)报收于105.59元，下跌2.17%，换手率1.13%，成交量4.5万手，成交额4.8亿元。该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为138.48。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800025812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0239","000661","BK0028","BK0057","BK0075"],"gpt_icon":0},{"id":"2486781812","title":"长春高新(SZ000661):公司将合理安排经营发展路径，遵守法律法规要求，审慎进行资本运作","url":"https://stock-news.laohu8.com/highlight/detail?id=2486781812","media":"问董秘","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486781812?lang=zh_cn&edition=full","pubTime":"2024-11-27 16:14","pubTimestamp":1732695240,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n投资者提问：请问贵司是否考虑把金蓓高分拆上市,扩大知名度更有利于产品推广董秘回答(长春高新SZ000661)：您好，公司会结合法律法规要求及各下属公司情况合理安排其经营发展路径，如有达到信息披露标准的资本运作事宜，公司会按照法律法规要求履行审议披露程序，谢谢！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-11-27/doc-incxnwin3542303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0075","BK0239","BK0188","BK0046","BK0057","000661"],"gpt_icon":0},{"id":"2486402651","title":"一位投资长春高新的老股民坦言：5年前5178点买入5万长春高新，无视涨跌到现在什么光景？真正的钱生钱","url":"https://stock-news.laohu8.com/highlight/detail?id=2486402651","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486402651?lang=zh_cn&edition=full","pubTime":"2024-11-26 16:39","pubTimestamp":1732610340,"startTime":"0","endTime":"0","summary":"5年前5178点买入5万长春高新，持有到2020年赚了多少?计算规则如下，1，5年前买入长春高新股票5万元并不在卖出。尽管长春高新在房地产上的投入不断增加，但是对业绩增长的主要贡献依旧是公司医药控股子公司的利润增长。因此，在下跌趋势中，股价实际上是在下降趋势线和下降支撑线中间的通道内运行。在此期间，股价多次受到上升趋势线的支撑和下降趋势阻力线的队碍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-26/doc-incxktkn4203907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0075","BK0057","000661","BK0188","BK0046","BK0239","BK0028"],"gpt_icon":0},{"id":"2485436282","title":"国金证券：给予长春高新买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2485436282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485436282?lang=zh_cn&edition=full","pubTime":"2024-11-21 14:10","pubTimestamp":1732169437,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维近期对长春高新进行研究并发布了研究报告《发布拟回购股份公告，彰显长期发展信心》，本报告对长春高新给出买入评级，当前股价为112.62元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级4家，增持评级2家；过去90天内机构目标均价为138.48。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100017665.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000661"],"gpt_icon":0},{"id":"2484690668","title":"《股市简讯》中国长春高新一度劲扬5.6%，拟以3-5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2484690668","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484690668?lang=zh_cn&edition=full","pubTime":"2024-11-18 14:00","pubTimestamp":1731909653,"startTime":"0","endTime":"0","summary":"《股市简讯》中国长春高新一度劲扬5.6%，拟以3-5亿元回购公司股份* 中国生长激素生产商--长春高新000661.SZ周一盘中一度升5.6%，稍早称拟以3-5亿元回购公司股份。* 中证医药100指数.CSI000978跌0.8%。* 长春高新公告称，拟以3-5亿元回购公司股份，回购价格不超过160.00元/股。（完）\n 更多股市简讯请点选CN-CMN-HOT (发稿 宿泱韫; 审校 林高丽) ((jenny.su@thomsonreuters.com; 86-10-56692102;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP0DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","000661","BK0046","BK0075","BK0188","BK0239","BK0057"],"gpt_icon":0},{"id":"2483849378","title":"长春高新最新公告：拟3亿元-5亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2483849378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483849378?lang=zh_cn&edition=full","pubTime":"2024-11-15 20:40","pubTimestamp":1731674452,"startTime":"0","endTime":"0","summary":"长春高新公告，公司拟使用自有资金及金融机构股票回购专项贷款资金3亿元-5亿元回购股份，全部用于后续实施公司及子公司核心团队股权激励或员工持股计划。回购价格不超过160.00元/股。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500040160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000661","BK0075","BK0057","BK0028","BK0046","BK0188"],"gpt_icon":0},{"id":"2483320150","title":"长春高新(000661.SZ)拟回购3亿元至5亿元公司股份 已获3.5亿元回购贷款承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=2483320150","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483320150?lang=zh_cn&edition=full","pubTime":"2024-11-15 20:38","pubTimestamp":1731674298,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长春高新(000661.SZ)发布公告，公司拟使用自有资金及金融机构股票回购专项贷款资金，以集中竞价交易方式回购部分公司已在境内发行的人民币普通股(A股)股票，全部用于后续实施公司及子公司核心团队股权激励或员工持股计划。本次拟回购资金总额不低于3亿元(含)、不超过5亿元(含)，回购价格不超过160元/股。截至公告披露日，公司已经取得了平安银行股份有限公司长春分行出具的《贷款承诺函》，同意为公司实施股票回购提供专项贷款项目提供金额3.5亿元、业务期限1年的贷款支持。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0057","BK0046","000661","BK0239","BK0075","BK0028","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-12-18","address":"吉林省长春市朝阳区高新区海容酒店及海茵广场写字楼B座2708室","stockEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":-0.1125},{"period":"3month","weight":0.2617},{"period":"6month","weight":0.0305},{"period":"1year","weight":-0.2543},{"period":"ytd","weight":-0.2805}],"companyName":"长春高新技术产业(集团)股份有限公司","boardCode":"AI0027","perCapita":"3006股","boardName":"医药制造业","registeredCapital":"40798万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 长春高新技术产业(集团)股份有限公司的主营业务为生物制药及中成药的研发、生产和销售，辅以房地产开发等业务。公司的主要产品为聚乙二醇重组人生长激素注射液、重组人生长激素、注射用重组人促卵泡激素、冻干水痘减毒活疫苗、人用狂犬病疫苗、血栓心脉宁片、银花泌炎灵片等。","serverTime":1734930308401,"listedPrice":8.8,"stockholders":"132885人(较上一季度减少2.16%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长春高新,000661,长春高新股票,长春高新股票老虎,长春高新股票老虎国际,长春高新行情,长春高新股票行情,长春高新股价,长春高新股市,长春高新股票价格,长春高新股票交易,长春高新股票购买,长春高新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长春高新(000661)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长春高新(000661)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}